Commonwealth Bank of Australia’s Agios Pharmaceuticals AGIO Stock Holding History

Commonwealth Bank of Australia’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-14,500	Closed	-$568K	–	780
2014 Q1	$568K	Sell	14,500 -15,500	-52%	-$519K	﹤0.01%	1003
2013 Q4	$719K	Buy	30,000 +15,877	+112%	+$362K	﹤0.01%	878
2013 Q3	$395K	Buy	+14,123	New	+$390K	﹤0.01%	1031

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TRV

Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return

FV2GP

Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Commonwealth Bank of Australia's AGIO Position: Q2 2014 in Review

Commonwealth Bank of Australia sold out of Agios Pharmaceuticals (AGIO) in Q2 2014, closing a stake of 14,500 shares — an estimated $568K sold.

Commonwealth Bank of Australia first reported a position in AGIO in Q3 2013 and held it in 3 quarters. The position peaked at $719K in Q4 2013. 99 funds tracked by Wall St. Rank hold AGIO as of Q2 2014.

Commonwealth Bank of Australia reported no remaining Agios Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
Commonwealth Bank of Australia sold 14,500 Agios Pharmaceuticals shares in Q2 2014, an estimated $568K.
Commonwealth Bank of Australia first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 3 quarters.
Commonwealth Bank of Australia's Agios Pharmaceuticals position peaked at $719K in Q4 2013.
99 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2014.

Based on Commonwealth Bank of Australia's 13F filing for Q2 2014, filed 11 Aug 2014.